Practice Areas · Healthcare & Life Sciences · Digital Health
Digital Health Lawyer Recruiters
Specialist search for digital health lawyers — law-firm regulatory groups, software and telehealth companies, and health systems building virtual care. US digital health startups raised $14.2 billion in 2025. The count of deals fell.
›Digital health lawyer recruiter
A digital health lawyer recruiter fills software, telehealth and AI-device seats at law firms and at companies. Rock Health recorded $14.2 billion of US digital health venture funding in 2025, across 482 deals. The FDA AI-enabled device list showed 1,614 rows on 7 October 2026, including 335 with a 2025 final decision. A CMS FAQ updated 26 February 2026 keeps Medicare telehealth flexibilities through 31 December 2027. Sartori & Partners has opened 11 digital health searches since 2023. A Series C remote-patient-monitoring company in Denver hired a product counsel in 8 weeks in 2025.
The dollars rose. The number of companies writing checks did not.
Dated prints for 2025 and early 2026. No public series counts digital health lawyers as its own occupation.
- $14.2B
- US digital health venture funding in 2025
- Rock Health, 12 January 2026
- 482
- deals in 2025, down from 509 in 2024
- Rock Health, 12 January 2026
- 335
- AI-enabled devices with a 2025 final decision
- FDA list, retrieved 7 October 2026
A digital health lawyer is the lawyer on the software, the virtual visit, or the model that will change after the device is authorized. The work is a marketing submission for an AI-enabled device software function, a telehealth arrangement whose Medicare payment depends on a dated waiver, or the contract stack of a company that sells both. It is not a drug-approval docket, and it is not a privacy notice with a healthcare logo on it. Firms hire it inside the FDA or healthcare group that staffs those matters. Companies hire it when the general counsel, or the founder if there is no general counsel, can no longer send every submission and every payer contract outside.
Rock Health's year-end overview, published 12 January 2026, put US digital health venture funding in 2025 at $14.2 billion, a 35 percent increase from $10.5 billion in 2024, and the highest annual total Rock Health has recorded since 2022. Rock Health said the year was not a return to the pandemic-era peak. The same overview put the fourth quarter at $4.2 billion across 129 deals, the highest quarter total it has logged since the second quarter of 2022. Startups raised $3.7 billion more than in 2024, and the deal count fell five percent, from 509 deals in 2024 to 482 in 2025. Average deal size rose to $29.3 million from $20.7 million. The median moved from $10 million to $12 million.
The gap between the average and the median is the hiring fact. Raises over $100 million accounted for 42 percent of 2025 funding, the highest share since 2021 and nearly double the prior year's share, across 26 mega deals. Fifteen companies became unicorns, up from six the year before. Rock Health's test is blunt: remove the nine companies that raised the most dollars in 2025, and total funding falls below 2024. A recruiter who staffs digital health off a rising startup count is staffing the wrong series. Fewer companies raised. The companies that raised, raised more. The seat that clears is a lawyer who has already lived inside one of those larger files, not a generalist who can say the sector is busy.
Artificial intelligence is where the concentration sits. Rock Health defines an AI-enabled digital health startup as one that uses artificial intelligence, machine learning, or deep learning as a core part of the product. In 2025, AI-enabled companies closed 50 percent of deals and captured 54 percent of funding, up from 37 percent of funding in 2024, with about a 19 percent premium on average deal size versus companies that did not put AI at the center of the product. The premium was widest at Series C, where Rock Health measured a 61 percent gap. Clinical and non-clinical workflow companies together took 39 percent of funding dollars. Fitness and wellness raised $2.0 billion across 44 deals. Those are product categories. They become legal work when the product is a device, a diagnostic, a benefit, or a care model that bills.
Exits moved the same direction as the dollars, and not in the same direction as the venture count. Merger and acquisition activity reached 195 deals in 2025, up 61 percent from 2024, after Rock Health described 2024 as a five-year low. Digital health companies were the acquirers on 66 percent of those deals, up from 53 percent in 2024, the highest share since Rock Health began tracking in 2013. Private equity firms were the acquirers on 10 percent. After two public exits in the prior three years, five companies listed in 2025: Hinge Health, Omada Health, Heartflow, Carlsmed, and Profusa. An acquisition or a listing is a different instruction from a Series B round. The buyer wants the rights to the data and the model, the quality of the clearance, and what the earnout does to the clinical claims. Thirty-five percent of 2025 venture rounds were unlabeled, Rock Health's term for a raise that is not a step up in round. That is a survival print sitting next to the mega-deal print. Both produce lawyer work. They do not produce the same job description.
There is no official census of digital health lawyers. The Bureau of Labor Statistics Occupational Employment and Wage Statistics for May 2025 reports 754,500 lawyer jobs in SOC 23-1011 and a mean annual wage of $185,840, and it does not split software, telehealth, or device work from any other practice. Sartori & Partners does not publish a separate digital-health headcount. The only firm-wide market-map figure is 1,480,000+ lawyers. The healthcare and life sciences practice is the parent field. Those counts are the digital-health search record and the public prints, not a second map.
The public list currently includes 35 live roles tagged to healthcare and to digital health, telehealth, device software, or artificial intelligence. Partner mandates in this practice are usually confidential and do not appear here. A role count is not a measure of demand.
Live digital health roles.
A guidance for the model that changes, and a statute for the visit at home.
The FDA document is dated 18 August 2025. The Medicare dates are in a CMS FAQ updated 26 February 2026. They are not the same hiring brief.
Two public clocks now decide whether a digital health brief is real. One is how an authorized device may change after it is on the market. The other is how long Medicare will pay for a non-behavioral visit when the patient is at home. A lawyer who has only one of them is the wrong shortlist for a company that has both, and a company that has only one should not be sold a search that pretends they are the same seat.
The Food and Drug Administration issued the final guidance "Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions" on 18 August 2025. The document states that it was originally issued on 4 December 2024. The Federal Register notice of that original issue is 4 December 2024. The guidance applies to AI-enabled devices, including the device constituent of a device-led combination product, reviewed through the 510(k), De Novo, and PMA pathways. A predetermined change control plan describes the planned modifications, the method used to develop, validate, and implement them, and an assessment of their impact. FDA reviews the plan as part of the marketing submission so that each listed modification does not need its own later submission. FDA's slides on the guidance state that a predetermined change control plan remains an optional mechanism. Optional is not the same as irrelevant. Once a sponsor puts the plan in the submission, it is part of the authorized device.
The agency's AI-Enabled Medical Device List is the count behind that guidance, and the agency says the list is not comprehensive. It identifies devices from AI-related terms in authorization summaries and classification, and it omits devices whose decision summaries were not published in the collection window. A retrieval of that list on 7 October 2026 contained 1,614 table rows. The latest Date of Final Decision on that retrieval was 29 June 2026. The earliest was 29 September 1995. Of those rows, 235 list a final decision in 2024, 335 list a final decision in 2025, and 181 list a final decision in 2026. The 2026 figure stops at 29 June 2026 because that is the latest decision on the list, not because the calendar year had ended. One row is already explicit about the plan: K252844, Tyto Insights for Wheeze Detection (with PCCP), final decision 2 June 2026. The interview question is whether the lawyer has put a plan of that kind into a submission, not whether the lawyer can name the guidance.
The payment clock is separate. Public Law 119-75, the Consolidated Appropriations Act, 2026, became law on 3 February 2026. CMS's Telehealth FAQ, updated 26 February 2026, states that through 31 December 2027 Medicare beneficiaries can receive telehealth services anywhere in the United States and its territories, and that starting 1 January 2028, except for behavioral health, beneficiaries will generally need to be in a medical facility and in a rural area. The same FAQ states that through 31 December 2027 an extended range of practitioners may bill, and that from 1 January 2028 physical therapists, occupational therapists, speech-language pathologists, and audiologists can no longer furnish Medicare telehealth. HHS's telehealth policy page states the same end date for non-behavioral care in the home and for the absence of a geographic limit on the originating site. Behavioral health is not on that cliff in the same way: the Consolidated Appropriations Act, 2021 permanently removed geographic and originating-site limits for behavioral health telehealth, which the February 2026 FAQ restates.
A company whose Medicare revenue is a home visit for a non-behavioral service is therefore hiring against a waiver that runs through 31 December 2027, not against a permanent benefit. The brief has to say which payers, which clinicians, and whether the model still works on 1 January 2028 if Congress does not move the date again. A device company whose product does not bill as Medicare telehealth does not have that cliff. Mixing the two briefs produces a shortlist that can discuss a 510(k) and cannot read a condition of payment, or the reverse.
Four buyers. They do not write the same job.
Software companies, device makers, law firms, and the systems and plans that pay for virtual care.
Digital health companies
Venture-backed software, telehealth, remote monitoring, and digital therapeutics. The seat is often a first counsel or a product counsel, reporting to a general counsel or to the chief executive when there is no general counsel yet.
Device and diagnostics makers
Manufacturers adding an AI-enabled device software function to a cleared product. The file is a 510(k), a De Novo, or a PMA, plus the predetermined change control plan if the model will change after authorization.
Law-firm regulatory groups
Partners, counsel, and associates hired into an FDA, healthcare, or privacy group when the matters are software and virtual care, not a drug approval or a malpractice docket.
Systems, payers, and platforms
Health systems, Medicare Advantage plans, and physician platforms standing up home-based care. The documents are conditions of payment, a professional-corporation structure, and the fraud-and-abuse analysis of how the product is sold.
Since 2023 Sartori & Partners has opened 11 digital health searches: 4 for law firms and 7 for companies. The firm-side searches were lateral partners, counsel, and senior associates moving into a group that staffs device software or virtual care. The company-side searches were product counsel and regulatory counsel reporting to a general counsel, or a first counsel where the company did not yet have one. Those 7 company searches are not a restatement of the 400+ placements since 2017 (230+ in-house), and they are not a general-counsel search. A general-counsel mandate has its own clock. This one does not.
Law firms hire when a healthcare partner's software product is thin, when a cohort of senior associates has left, or when a lateral group arrives without the lawyer who used to clear their device submissions. The conflicts check comes before any approach. A regulatory partner's book is often a share of other partners' life-sciences clients. Portability is a question about those relationships, not a revenue number copied from a biography. Associate hiring is a different screen: class year, and whether "digital health" on the form is a software submission or a year of HIPAA policies with a telehealth contract attached.
Companies hire when the person who can defend the clearance sits at a law firm and the person who signs the customer contract sits inside. The usual trigger is a financing that makes the company look durable, a clearance the board has promised, or a payer contract the sales team is already marking up. The reporting line is part of the brief. Some seats report to the general counsel. Some, at an earlier company, report to the chief executive and are the legal function. A search that does not decide that line produces two shortlists and a stalled offer. Sponsors and acquirers hire a thinner bench: one counsel who can live on the purchase agreement, the quality system, and the question of who owns the training data. Rock Health's 195 deals in 2025 are why that stack is not a footnote. Digital health companies themselves were the buyer on 66 percent of them.
Health systems, plans, and physician platforms hire for the payment and the structure, not for a 510(k). The question is which clinicians may bill, where the patient may sit, and how the management-services arrangement is written so that it is not an impermissible split of a professional fee. That work sits next to fraud and abuse when the product steers a referral. It is still digital health. It is not the same resume as a predetermined change control plan. We ask which of the four buyers the last three matters were for before we describe the seat as filled.
The matching market article is med-tech and digital-health regulatory counsel. It covers the in-house device seat for companies selling into the European Union and Great Britain: who holds the conformity route, and why a regulatory-affairs team is not that lawyer. A product that must carry a European or UK mark is that article's subject. A US law-firm or company hire is one of the four buyers: a software company, a device maker, a law firm, or a system or plan. The therapeutics sibling is whether life sciences law is hiring in 2026. A drug-approval lawyer and a software lawyer are not substitutes.
What the interview is actually testing.
A submission, a payment rule, or a corporate structure. Not a digital-health label.
A useful digital health interview walks a file, not a sector. The questions that separate this seat from a general healthcare seat are concrete. Did the lawyer prepare a 510(k), a De Novo, or a PMA for a device software function, and can they say which modifications were put inside a predetermined change control plan rather than left for a later submission? On a product authorized in 2025 or 2026, did they apply the guidance issued on 18 August 2025, or are they describing a 2022 memo? Can they point to a row on the FDA list and say what the summary actually committed the company to, the way K252844's clearance letter carries the plan in the device name?
Telehealth is its own stack. The lawyer should be able to say, from the CMS FAQ updated 26 February 2026, where the patient may be through 31 December 2027 and what changes on 1 January 2028 for a non-behavioral service. They should be able to separate that waiver from behavioral health, which the same FAQ treats as already free of the rural and facility limits under the 2021 statute. A candidate who calls all of this "COVID flexibilities" and cannot give the two dates has not read the current rule. A candidate who can give the dates and has never papered a professional-corporation or a management-services agreement has a different gap. We do not treat those resumes as the same.
Privacy is relevant when the product collects health information, and it is not a substitute for the submission or the payment rule. A HIPAA policy, a state consumer-health statute, and an FDA device file answer different questions. The sibling page for privacy without the device or the virtual-care model is HIPAA and health privacy. The sibling page for an FDA practice that is not this software seat is FDA regulatory. A mandate that is a drug or biologic approval belongs with life sciences or pharmaceutical work. A mandate that is a signing of software, a change-control plan, or a home-based Medicare service belongs here. Mixing them produces a shortlist that cannot close.
A chief compliance officer search is a different mandate again. It is run as compliance recruitment, and it carries the 12-month replacement term that applies to that office. A product counsel or a regulatory counsel on a digital health brief is not that office unless the client says so in the letter. We do not widen the title to make the pool look larger.
The paycheck is a scale, or a company band. It is not a digital-health premium.
Law-firm associates sit on the 2026 matching scale. In-house cash is a different book. Neither figure is a digital-health premium.
Legal Business, on 3 June 2026, reported that Milbank's 2 June 2026 announcement took the scale-firm first-year base to $235,000, effective 1 July 2026, and that McDermott matched. Biglaw Investor publishes the eighth-year base on that ladder at $455,000. A digital health associate at a firm that matched is paid on that ladder, at the class year, alongside the regulatory associate on the same submission. Nothing in the 2025 funding prints adds a published premium above that ladder. Quoting the scale as "digital health pay" without the class year misstates the offer. The class-year table, and the warning not to price an in-house seat off a compliance-officer mean, is on healthcare attorney salary 2026. The ladder itself is on the 2026 associate scale.
In-house digital health counsel is not that ladder. The Association of Corporate Counsel 2025 Law Department Compensation Survey, data effective 1 March 2025 and based on 1,632 respondents, puts the Attorney median base at $148,000 and median total cash at $160,000. Those are all-industry title bands, not a digital-health cut, and they are the bands a general counsel actually has in the survey. A company that copies $235,000, a first-year firm base, onto a counsel seat, or that copies a compliance-officer wage onto a lawyer seat, is pricing a different job. The all-industry in-house ladder is on in-house counsel salary 2026. No filing we rely on isolates a digital-health-counsel average, so none is stated here.
The Bureau of Labor Statistics figure is a third object. OEWS for May 2025 puts the mean annual wage for lawyers at $185,840 across 754,500 jobs. That mean is not an offer, and it is not a digital-health offer. It is the reason a census cannot be used to price this seat. Partner compensation is not a scale either. It is points, a share of collections, and whatever the partnership agreement does with a guaranteed draw. Nothing in the Rock Health prints is a partner's paycheck. We do not convert a funding round into a lateral partner number.
Our fee, on every retained search, is 25–30 percent of the hire's total first-year compensation. Thirty percent of the fee is paid as a retainer when the search is engaged, and that retainer is kept if the client cancels. There is no contingency option. The same terms apply whether the seat is a law-firm counsel or an in-house product counsel. Offer acceptance on retained corporate searches is 96 percent. That rate is the corporate book, not a separate digital-health rate.
What we have actually run on this seat.
A short book of digital health searches since 2023. The clocks are that book, not the general-counsel clock.
On the 11 digital health searches opened since 2023, the median time to a shortlist was 19 days, and the median time to an accepted offer was 9 weeks. Both medians are taken on the searches in that set that reached an offer. They are not the 24-day and 11-week medians that apply to general counsel and chief legal officer searches. Using the general-counsel clock on a product counsel overstates the calendar we have seen on this seat, and it mixes two books.
One of those company searches closed in 2025. A Series C remote-patient-monitoring company in Denver hired a product counsel in 8 weeks. The brief was a counsel who had prepared a 510(k) for device software and could read a Medicare telehealth condition of payment, reporting to the general counsel. The general counsel later said: The shortlist had counsel who had filed a 510(k) for device software, and counsel who had only reviewed a privacy policy. We hired from the first group.
The 4 law-firm searches were a mix of counsel and partner laterals and senior associates. Where they slowed down, they slowed on conflicts: the regulatory partner the firm wanted was already on the other side of a live submission, or the book was a life-sciences partner's clients who were not going to move. The 7 company searches slowed, when they slowed, on the reporting line and on cash against the law-firm scale. A counsel who sits on the $235,000-to-$455,000 ladder does not experience an in-house offer at the ACC Attorney median base of $148,000 as a raise just because the title changed.
In-house searches other than general counsel, chief legal officer, and chief compliance officer carry a 6-month replacement guarantee. Those three seats carry 12 months. A digital health product counsel is in the 6-month group unless the brief is actually one of those three offices. We do not recruit from a client's legal department for 24 months after a mandate, and we do not approach a lawyer we placed for as long as that lawyer stays in the seat.
The working sequence is the one we use on retained corporate and law-firm work. The first week is the brief: which of the four buyers, whether the file is a submission, a payment rule, or both, the reporting line, and the cities where the person must be admitted or willing to sit. Mapping and private outreach follow. A name does not go to the client without the candidate's consent. Candidates who want a confidential conversation start at submit your CV. Companies and firms that already have a seat start at talk or contact.
The searches we run in digital health.
Law-firm and company mandates. Same standard of evidence, different documents.
Lateral partner and counsel
Healthcare regulatory partners and counsel whose book is device software, telehealth, or an AI-enabled device function. Conflicts and whether the clients will move come before any approach.
Explore this search 02In-house product and regulatory counsel
The lawyer who sits with a general counsel and can take a 510(k), a predetermined change control plan, or a Medicare telehealth model without sending every step outside.
Explore this search 03Associate and counsel depth
Mid-level and senior associates who have staffed a software submission or a virtual-care contract. Class year is the pay scale. The file is the screen.
Explore this search 04Health-system and payer virtual care
Counsel for a system, a plan, or a management-services organization whose virtual-care revenue depends on a waiver that now runs through 31 December 2027.
Explore this searchParent practice, the device article, and the pay pages.
Healthcare is the parent practice. Pay and the European device seat are neighboring briefs.
Healthcare and life sciences recruitment is the parent. FDA regulatory is the sibling for approvals that are not this software seat. HIPAA and health privacy is the sibling for privacy without the device file or the virtual-care model. Life sciences is the therapeutics field on the same companies when the product is a drug or a biologic rather than software. Companies comparing cash should use healthcare attorney salary 2026, the 2026 associate scale, and in-house counsel salary 2026. A general counsel hiring for a European or UK conformity route should use the market note on med-tech and digital-health regulatory counsel.
Law firms briefing a lateral start with for law firms and partner recruiting or associate recruiting. Companies start with for companies and in-house counsel recruiting.
The prints behind the figures.
Funding, the device list, the guidance, the telehealth dates, the associate scale, and the lawyer wage. Internal search counts are not in this list.
- Rock Health, 2025 year-end digital health funding overview, 12 January 2026 — US venture funding $14.2 billion, up 35 percent from $10.5 billion in 2024; Q4 $4.2 billion across 129 deals; 482 deals versus 509, average $29.3 million versus $20.7 million, median $12 million versus $10 million; raises over $100 million were 42 percent of funding across 26 mega deals; 15 new unicorns; AI-enabled companies 50 percent of deals and 54 percent of funding, up from 37 percent, with about a 19 percent average-deal premium and a 61 percent Series C premium; workflow 39 percent of dollars; fitness and wellness $2.0 billion across 44 deals; M&A 195 deals, up 61 percent, digital health companies 66 percent of acquirers, private equity 10 percent; five IPOs after two public exits in the prior three years; 35 percent of rounds unlabeled.
- FDA, AI-Enabled Medical Device List — retrieved 7 October 2026. The agency states the list is not comprehensive. That retrieval contained 1,614 rows. Final-decision years on those rows: 235 in 2024, 335 in 2025, 181 in 2026. Latest final decision 29 June 2026. Earliest 29 September 1995. K252844, Tyto Insights for Wheeze Detection (with PCCP), final decision 2 June 2026.
- FDA guidance on a predetermined change control plan for AI-enabled device software functions — issued 18 August 2025; the document states it was originally issued 4 December 2024. Federal Register notice: 4 December 2024. Applies to 510(k), De Novo, and PMA, including the device constituent of a device-led combination product. Slides stating the plan remains optional: FDA, 2025.
- Public Law 119-75 — Consolidated Appropriations Act, 2026, H.R. 7148, became law 3 February 2026.
- CMS, Telehealth FAQ, updated 26 February 2026 — through 31 December 2027, Medicare telehealth anywhere in the United States; from 1 January 2028, except behavioral health, generally a medical facility in a rural area. Extended practitioner list through 31 December 2027. Behavioral health geographic and originating-site limits removed by the Consolidated Appropriations Act, 2021.
- HHS, Telehealth policy updates — non-behavioral Medicare telehealth in the home, and no geographic restriction on the originating site, through 31 December 2027.
- Bureau of Labor Statistics, OEWS Table 1, May 2025 — SOC 23-1011, lawyers: mean annual wage $185,840; 754,500 jobs. No digital-health split.
- Legal Business, 3 June 2026 — first-year base $235,000 after Milbank's 2 June 2026 announcement, effective 1 July 2026; McDermott matched. Eighth-year base $455,000: Biglaw Investor.
- ACC / Empsight, 2025 Law Department Compensation Survey — data effective 1 March 2025, 1,632 respondents. Attorney median base $148,000; Attorney median total cash $160,000. Not a digital-health cut.
Digital health recruitment — common questions
What does a digital health lawyer recruiter do?
A digital health lawyer recruiter fills software, telehealth, and AI-device seats at law firms and at companies. Rock Health, on 12 January 2026, recorded $14.2 billion of US digital health venture funding in 2025, across 482 deals, up 35 percent from $10.5 billion in 2024. The FDA AI-enabled device list, retrieved 7 October 2026, showed 1,614 rows, including 335 with a 2025 final decision. Sartori & Partners has opened 11 digital health searches since 2023. A Series C remote-patient-monitoring company in Denver hired a product counsel in 8 weeks in 2025.
Who hires digital health lawyers?
Four categories hire this seat: digital health companies; device and diagnostics manufacturers adding an AI-enabled device software function; law-firm FDA, healthcare, and privacy groups; and health systems, payers, and physician platforms standing up virtual care. Of the 11 searches opened since 2023, 4 were for law firms and 7 were for companies. A CMS FAQ updated 26 February 2026 states that, through 31 December 2027, Medicare beneficiaries can receive telehealth anywhere in the United States. From 1 January 2028, except for behavioral health, they will generally need to be in a medical facility in a rural area.
What do digital health lawyers earn in 2026?
No public series isolates a digital-health premium. Legal Business, on 3 June 2026, reported a scale-firm first-year base of $235,000 after Milbank's 2 June 2026 announcement, effective 1 July 2026. Biglaw Investor publishes the eighth-year base at $455,000. The Association of Corporate Counsel 2025 Law Department Compensation Survey, data effective 1 March 2025 across 1,632 respondents, puts Attorney median base at $148,000 and median total cash at $160,000. BLS OEWS for May 2025 reports a lawyer mean of $185,840 and 754,500 jobs, with no digital-health line. Bands are on the healthcare attorney salary page. A retained search is 25–30 percent of first-year total compensation, and 30 percent of that fee is the retainer.
How long does a digital health search take?
Across the 11 digital health searches opened since 2023, the median time to a shortlist was 19 days and the median time to an accepted offer was 9 weeks, on the searches in that set that reached an offer. The Series C remote-patient-monitoring company in Denver accepted its product counsel in 8 weeks in 2025. Those clocks are not the 24-day shortlist and 11-week offer that apply to general counsel and chief legal officer searches. Offer acceptance on retained corporate searches is 96 percent. In-house searches other than general counsel, chief legal officer, and chief compliance officer carry a 6-month replacement guarantee; those three seats carry 12 months.
Digital Health
The hire on a software file starts with a quiet conversation.
Tell us the mandate — firm or company, a submission or a payment rule, partner or counsel. We will tell you whether we are the right firm to run it.